Diego Alberto Bárcenas-López

ORCID: 0000-0002-1803-0633
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Lymphoblastic Leukemia research
  • Childhood Cancer Survivors' Quality of Life
  • Acute Myeloid Leukemia Research
  • RNA modifications and cancer
  • Cancer-related molecular mechanisms research
  • Epigenetics and DNA Methylation
  • Circular RNAs in diseases
  • MicroRNA in disease regulation
  • Cancer therapeutics and mechanisms
  • Renal and Vascular Pathologies
  • Chronic Myeloid Leukemia Treatments
  • Lymphoma Diagnosis and Treatment
  • Stress Responses and Cortisol
  • CAR-T cell therapy research
  • Chronic Lymphocytic Leukemia Research
  • Mycobacterium research and diagnosis
  • RNA Interference and Gene Delivery
  • Vascular Procedures and Complications
  • Biosimilars and Bioanalytical Methods
  • Peripheral Artery Disease Management
  • Anesthesia and Neurotoxicity Research
  • Global Cancer Incidence and Screening
  • Cancer Risks and Factors
  • Colorectal Cancer Screening and Detection

Children's Hospital of Philadelphia
2024-2025

Universidad Nacional Autónoma de México
2019-2024

National Institute of Genomic Medicine
2016-2024

Massachusetts General Hospital
2018-2020

Evidence showing the role of long non-coding RNAs (lncRNAs) in leukemogenesis have emerged last decade. It has been proposed that these genes can be used as diagnosis and/or prognosis biomarkers childhood acute lymphoblastic leukemia (ALL). To know if lncRNAs are associated with early relapse and mortality, a microarray-based gene expression analysis children B-lineage ALL (B-ALL) was conducted. Cox regression analyses were performed. Hazard ratios (HR) 95% confidence intervals (95% CI)...

10.3390/genes11030302 article EN Genes 2020-03-13

Acute lymphoblastic leukemia (ALL) represents around 25% of adult acute leukemias. Despite the increasing improvement in survival rate ALL patients during last decade, heterogeneous clinical and molecular features this malignancy still represent a major challenge for treatment achieving better outcomes. To identify aberrantly expressed genes bone marrow (BM) samples from adults with ALL, transcriptomic analysis was performed using Affymetrix Human Transcriptome Array 2.0 (HTA 2.0)....

10.3390/ijms25031750 article EN International Journal of Molecular Sciences 2024-02-01

Objective: The aim of this study was to determine the association between presence chronic medical disease and mammography screening adherence. Materials Methods: We performed a retrospective on women ages 50 64 who received in 2005 had at least 8 years follow-up. Demographic clinical information obtained from our centralized patient data registry. Women diagnosed with one or more following diseases for 3 months before their index mammogram were considered have disease, including atrial...

10.1089/jwh.2018.7315 article EN Journal of Women s Health 2018-12-19

B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is the most frequent pediatric cancer worldwide. Despite improvements in treatment regimens, approximately 20% of cases cannot be cured, highlighting necessity for identifying new biomarkers to improve current clinical and molecular risk stratification schemes. We aimed investigate whether LINC00173 a biomarker ALL explore its expression level other human types.A nested case-control study including Mexican children with BCP-ALL was...

10.3389/fonc.2022.887766 article EN cc-by Frontiers in Oncology 2022-06-02
Coming Soon ...